Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

The collection of research initiatives that together comprise this project draw on clinical and economic expertise along with novel data sets and analytical tools to analyze the decision-making ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...

Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.

ABC 17 News Anchor Meghan Drakas is sharing her family's experience with Alzheimer's disease along with other members of the ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...